Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/4/2026 | 2,099 | 0.0% | 31,614 | 12/31/2025 |
| 2025 Q3 | 10/24/2025 | 1,076 | 0.0% | 31,184 | 9/30/2025 |
| 2025 Q2 | 7/25/2025 | 452 | 0.0% | 28,584 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 368 | 0.0% | 28,884 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 476 | 0.0% | 25,338 | 12/31/2024 |
| 2024 Q3 | 10/29/2024 | 491 | 0.0% | 25,338 | 9/30/2024 |
| 2024 Q2 | 8/2/2024 | 672 | 0.0% | 25,838 | 6/30/2024 |
| 2024 Q1 | 5/3/2024 | 876 | 0.0% | 30,638 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 927 | 0.0% | 30,308 | 12/31/2023 |
| 2023 Q3 | 10/27/2023 | 809 | 0.0% | 30,108 | 9/30/2023 |
| 2023 Q2 | 7/26/2023 | 1,102 | 0.0% | 30,908 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 803 | 0.0% | 31,608 | 3/31/2023 |
| 2022 Q4 | 1/26/2023 | 1,265 | 0.0% | 31,180 | 12/31/2022 |
| 2022 Q3 | 11/2/2022 | 1,020 | 0.0% | 30,851 | 9/30/2022 |
| 2022 Q2 | 7/25/2022 | 1,086 | 0.0% | 30,851 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 1,532 | 0.0% | 33,320 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 2,262 | 0.0% | 34,120 | 12/31/2021 |
| 2021 Q3 | 10/19/2021 | 2,192 | 0.0% | 35,106 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 2,933 | 0.0% | 35,413 | 6/30/2021 |
| 2021 Q1 | 4/20/2021 | 2,265 | 0.0% | 34,158 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 2,604 | 0.0% | 33,933 | 12/31/2020 |
| 2020 Q3 | 11/3/2020 | 1,490 | 0.0% | 34,610 | 9/30/2020 |
| 2020 Q2 | 7/21/2020 | 1,605 | 0.0% | 37,158 | 6/30/2020 |
| 2020 Q1 | 4/20/2020 | 1,083 | 0.0% | 37,658 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 2,406 | 0.0% | 37,935 | 12/31/2019 |